Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0001104659-25-038121·Oncology Institute, Inc.
Schedule 13D ownership disclosure
Oncology Institute Inc/The
Common Stock, par value $0.0001 per share · CUSIP: 68236X100
Event date: 2025-03-26
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Ravi SarinReported CIK 0001555959
Shares: 4,109,771.00 · Class: 4.7%
- OncologyCare Partners, LLCReported CIK 0001752450
Shares: 4,109,771.00 · Class: 4.7%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-25-038121
- Form type
- SCHEDULE 13D/A
- Filer
- Oncology Institute, Inc.
- CIK
- CIK 1799191
- Filed
- Apr 23, 2025
- Reporting period
- Mar 26, 2025
- Description
- Schedule 13D beneficial ownership